QCI Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $284K | Hold |
1,999
| – | – | 0.02% | 125 |
|
|
2021
Q2 | $312K | Sell |
1,999
-31
| -2% | -$5.02K | 0.02% | 121 |
|
|
2021
Q1 | $316K | Sell |
2,030
-155
| -7% | -$24K | 0.02% | 122 |
|
|
2020
Q4 | $327K | Buy |
2,185
+41
| +2% | +$5.79K | 0.02% | 114 |
|
|
2020
Q3 | $283K | Sell |
2,144
-93
| -4% | -$12.1K | 0.02% | 105 |
|
|
2020
Q2 | $259K | Sell |
2,237
-28
| -1% | -$3.23K | 0.02% | 105 |
|
|
2020
Q1 | $222K | Sell |
2,265
-7,916
| -78% | -$1.04M | 0.02% | 112 |
|
|
2019
Q4 | $1.48M | Sell |
10,181
-150,222
| -94% | -$20.7M | 0.13% | 66 |
|
|
2019
Q3 | $21.4M | Buy |
160,403
+6,125
| +4% | +$791K | 1.92% | 19 |
|
|
2019
Q2 | $17.6M | Buy |
154,278
+3,480
| +2% | +$408K | 1.68% | 29 |
|
|
2019
Q1 | $18.7M | Buy |
150,798
+5,035
| +3% | +$572K | 1.84% | 21 |
|
|
2018
Q4 | $14.7M | Buy |
145,763
+662
| +0.5% | +$74.4K | 1.61% | 29 |
|
|
2018
Q3 | $18.5M | Buy |
145,101
+1,168
| +0.8% | +$139K | 1.76% | 18 |
|
|
2018
Q2 | $15.6M | Buy |
143,933
+3,276
| +2% | +$357K | 1.56% | 33 |
|
|
2018
Q1 | $14.9M | Buy |
140,657
+1,385
| +1% | +$161K | 1.58% | 31 |
|
|
2017
Q4 | $16.3M | Buy |
139,272
+2,793
| +2% | +$316K | 1.67% | 23 |
|
|
2017
Q3 | $15.5M | Buy |
136,479
+2,702
| +2% | +$312K | 1.73% | 21 |
|
|
2017
Q2 | $16.7M | Buy |
133,777
+1,720
| +1% | +$204K | 2.01% | 8 |
|
|
2017
Q1 | $15.7M | Buy |
132,057
+1,571
| +1% | +$178K | 1.98% | 12 |
|
|
2016
Q4 | $13.1M | Buy |
130,486
+3,097
| +2% | +$332K | 1.75% | 25 |
|
|
2016
Q3 | $16.1M | Sell |
127,389
-1,508
| -1% | -$186K | 2.24% | 7 |
|
|
2016
Q2 | $15.1M | Buy |
128,897
+1,705
| +1% | +$193K | 2.13% | 11 |
|
|
2016
Q1 | $13.2M | Buy |
127,192
+3,969
| +3% | +$384K | 1.93% | 18 |
|
|
2015
Q4 | $12.3M | Buy |
123,223
+1,768
| +1% | +$173K | 1.9% | 21 |
|
|
2015
Q3 | $11.1M | Buy |
121,455
+1,962
| +2% | +$197K | 1.81% | 21 |
|
|
2015
Q2 | $12.7M | Buy |
119,493
+1,738
| +1% | +$192K | 1.97% | 15 |
|
|
2015
Q1 | $13.4M | Sell |
117,755
-7,071
| -6% | -$807K | 2.1% | 11 |
|
|
2014
Q4 | $13.7M | Sell |
124,826
-2,868
| -2% | -$302K | 2.13% | 7 |
|
|
2014
Q3 | $12.5M | Buy |
127,694
+1,200
| +0.9% | +$118K | 1.95% | 15 |
|
|
2014
Q2 | $12.8M | Sell |
126,494
-1,571
| -1% | -$153K | 1.99% | 15 |
|
|
2014
Q1 | $11.8M | Sell |
128,065
-2,261
| -2% | -$208K | 1.9% | 15 |
|
|
2013
Q4 | $11.8M | Sell |
130,326
-255
| -0.2% | -$22.1K | 1.93% | 18 |
|
|
2013
Q3 | $10.4M | Buy |
130,581
+323
| +0.2% | +$25.4K | 1.87% | 20 |
|
|
2013
Q2 | $9.48M | Buy |
+130,258
| New | +$9.74M | 1.79% | 24 |
|
Other funds holding ZBH
QCI Asset Management's ZBH Position: Q3 2021 in Review
QCI Asset Management held its Zimmer Biomet (ZBH) position steady in Q3 2021 at 1,999 shares worth $284K. The position accounts for 0.02% of the portfolio, ranked #125.
QCI Asset Management first reported a position in ZBH in Q2 2013 and has held it in 34 quarters since. The position peaked at $21.4M in Q3 2019. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.
- QCI Asset Management held 1,999 shares of Zimmer Biomet worth $284K as of Q3 2021.
- QCI Asset Management left its Zimmer Biomet share count unchanged in Q3 2021.
- Zimmer Biomet made up 0.02% of QCI Asset Management's portfolio in Q3 2021, its #125 holding.
- QCI Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 34 quarters since.
- QCI Asset Management's Zimmer Biomet position peaked at $21.4M in Q3 2019.
- 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.
Based on QCI Asset Management's 13F filing for Q3 2021, filed 4 Nov 2021.